REGIONAL HEALTH PROPERTIES (RHE)
US75903M3097 - Common Stock
We assign a fundamental rating of 1 out of 10 to RHE. RHE was compared to 107 industry peers in the Health Care Providers & Services industry. RHE has a bad profitability rating. Also its financial health evaluation is rather negative. RHE has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
RHE had negative earnings in the past year.
In the past year RHE had a positive cash flow from operations.
RHE had negative earnings in 4 of the past 5 years.
Of the past 5 years RHE 4 years had a positive operating cash flow.
1.2 Ratios
The Return On Assets of RHE (-4.81%) is worse than 63.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.81% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)10.26%
ROA(5y)3.75%
ROE(3y)6943.44%
ROE(5y)4142.66%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 49.69%, RHE is in the better half of the industry, outperforming 78.10% of the companies in the same industry.
RHE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 49.69% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
RHE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RHE has more shares outstanding
Compared to 5 years ago, RHE has more shares outstanding
Compared to 1 year ago, RHE has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -1.81, we must say that RHE is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -1.81, RHE is not doing good in the industry: 82.86% of the companies in the same industry are doing better.
RHE has a debt to FCF ratio of 60.13. This is a negative value and a sign of low solvency as RHE would need 60.13 years to pay back of all of its debts.
RHE has a Debt to FCF ratio of 60.13. This is comparable to the rest of the industry: RHE outperforms 49.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 60.13 | ||
| Altman-Z | -1.81 |
ROIC/WACCN/A
WACC5.06%
2.3 Liquidity
A Current Ratio of 0.29 indicates that RHE may have some problems paying its short term obligations.
RHE's Current ratio of 0.29 is on the low side compared to the rest of the industry. RHE is outperformed by 94.29% of its industry peers.
A Quick Ratio of 0.29 indicates that RHE may have some problems paying its short term obligations.
RHE has a Quick ratio of 0.29. This is amonst the worse of the industry: RHE underperforms 94.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.29 | ||
| Quick Ratio | 0.29 |
3. Growth
3.1 Past
The earnings per share for RHE have decreased strongly by -108.34% in the last year.
Looking at the last year, RHE shows a very negative growth in Revenue. The Revenue has decreased by -24.56% in the last year.
RHE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.88% yearly.
EPS 1Y (TTM)-108.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.19%
Revenue 1Y (TTM)-24.56%
Revenue growth 3Y-0.79%
Revenue growth 5Y-4.88%
Sales Q2Q%2.05%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for RHE. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
RHE's Enterprise Value to EBITDA is on the same level as the industry average.
RHE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. RHE is cheaper than 98.10% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.76 | ||
| EV/EBITDA | 27.97 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
RHE does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
REGIONAL HEALTH PROPERTIES
NYSEARCA:RHE (1/8/2025, 8:25:57 PM)
After market: 2.49 +0.13 (+5.51%)2.36
-0.13 (-5.22%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners2.13%
Inst Owner Change0%
Ins Owners14.05%
Ins Owner Change0%
Market Cap4.44M
Analysts0
Price TargetN/A
Short Float %0.71%
Short Ratio0.56
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)90.1%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.26 | ||
| P/FCF | 5.76 | ||
| P/OCF | 3.57 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 27.97 |
EPS(TTM)-1.55
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.41
FCFY17.35%
OCF(TTM)0.66
OCFY27.99%
SpS9.15
BVpS-1.27
TBVpS-3.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.81% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 49.69% | ||
| FCFM | 4.48% |
ROA(3y)10.26%
ROA(5y)3.75%
ROE(3y)6943.44%
ROE(5y)4142.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.29
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 60.13 | ||
| Debt/EBITDA | 25.78 | ||
| Cap/Depr | 23.41% | ||
| Cap/Sales | 2.74% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 69.15% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.29 | ||
| Quick Ratio | 0.29 | ||
| Altman-Z | -1.81 |
F-Score4
WACC5.06%
ROIC/WACCN/A
Cap/Depr(3y)19.64%
Cap/Depr(5y)15.23%
Cap/Sales(3y)2.27%
Cap/Sales(5y)1.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-108.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.19%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-24.56%
Revenue growth 3Y-0.79%
Revenue growth 5Y-4.88%
Sales Q2Q%2.05%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y79.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y148.86%
FCF growth 3Y48.26%
FCF growth 5Y22.22%
OCF growth 1Y189.42%
OCF growth 3Y42.05%
OCF growth 5Y22.46%